Lifeward Ltd.
Key Metrics
- Previous Close
- $3.10
- 52-Week Range
- $3.04 – $9.61
- Market Cap
- $9.08M
- P/E (TTM)
- —
- EPS (TTM)
- -15.73
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 1.25
- PEG Ratio
- —
- Return on Equity
- -326.76%
- Return on Assets
- -60.97%
- Gross Margin
- 31.47%
- Operating Margin
- -124.37%
- Profit Margin
- -155.37%
- Current Ratio
- 2.00
- Debt/Equity
- 1.32
- Total Debt
- $9.61M
- Free Cash Flow
- $-10.40M
- Revenue Growth
- -12.40%
- Earnings Growth
- —
- Enterprise Value
- $14.14M
Market Snapshot
About
Lifeward Ltd. is a medical technology company developing exoskeleton systems for individuals with mobility impairments. The company's flagship product is a wearable robotic exoskeleton designed to enable people with lower-limb disabilities to stand, walk, and climb stairs. Lifeward focuses on advancing rehabilitation technology and improving quality of life for those with spinal cord injuries and other mobility challenges.